Preferred Name | Fluoxymesterone | |
Synonyms |
|
|
Definitions |
A halogenated derivative of 17-alpha-methyltestosterone. Similar to testosterone, fluoxymesterone binds to and activates specific nuclear receptors, resulting in an increase in protein anabolism, a decrease in amino acid catabolism, and retention of nitrogen, potassium, and phosphorus. This agent also may competitively inhibit prolactin receptors and estrogen receptors, thereby inhibiting the growth of hormone-dependent tumor lines. Fluoxymesterone is approximately five times more potent than methyltestosterone. (NCI04) |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C507 |
|
CAS_Registry |
76-43-7 |
|
CHEBI_ID |
CHEBI:5120 |
|
Chemical_Formula |
C20H29FO3 |
|
code |
C507 |
|
Contributing_Source |
FDA |
|
definition |
A halogenated derivative of 17-alpha-methyltestosterone. Similar to testosterone, fluoxymesterone binds to and activates specific nuclear receptors, resulting in an increase in protein anabolism, a decrease in amino acid catabolism, and retention of nitrogen, potassium, and phosphorus. This agent also may competitively inhibit prolactin receptors and estrogen receptors, thereby inhibiting the growth of hormone-dependent tumor lines. Fluoxymesterone is approximately five times more potent than methyltestosterone. (NCI04) |
|
FDA_UNII_Code |
9JU12S4YFY |
|
in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 http://purl.obolibrary.org/obo/NCIT_C177537 http://purl.obolibrary.org/obo/NCIT_C176424 http://purl.obolibrary.org/obo/NCIT_C128784 |
|
Is_Value_For_GDC_Property | ||
label |
Fluoxymesterone |
|
Legacy Concept Name |
Fluoxymesterone |
|
Maps_To |
Fluoxymesterone |
|
NCI_Drug_Dictionary_ID |
494707 |
|
NSC Number |
12165 |
|
PDQ_Closed_Trial_Search_ID |
494707 |
|
PDQ_Open_Trial_Search_ID |
494707 |
|
Preferred_Name |
Fluoxymesterone |
|
prefixIRI |
NCIT:C507 |
|
prefLabel |
Fluoxymesterone |
|
Semantic_Type |
Organic Chemical Pharmacologic Substance |
|
UMLS_CUI |
C0016366 |
|
subClassOf |